Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

It is feasible and safe to stop specialized follow-up of asymptomatic lower risk chronic lymphocytic leukemia

Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten Utoft Niemann

Blood Adv bloodadvances.2023012382.

https://doi.org/10.1182/bloodadvances.2023012382

Published: 2024

Includes: Supplemental data

Journal Articles

CLL-IPI applied in Binet A CLL: a nationwide cohort study

Emelie C. Rotbain, Caspar da Cunha-Bang, Christian Brieghel, Carsten U. Niemann

Blood Adv (2022) 6 (21): 5698–5701.

https://doi.org/10.1182/bloodadvances.2021006259

Published: 2022

Includes: Supplemental data

Journal Articles

Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data

Mehdi Parviz, Christian Brieghel, Rudi Agius, Carsten U. Niemann

Blood Adv (2022) 6 (12): 3716–3728.

https://doi.org/10.1182/bloodadvances.2021006351

Published: 2022

Includes: Supplemental data